Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Fate Therapeutics, Inc. (FATE) had Current Assets of $291.91M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$13.63M |
|
$-186.26M |
|
-- |
|
$13.63M |
|
$223.91M |
|
$-210.28M |
|
$24.01M |
|
$-186.26M |
|
$-186.26M |
|
$-186.26M |
|
$-186.26M |
|
$-186.26M |
|
$-186.26M |
|
$-210.28M |
|
$-200.39M |
|
113.69M |
|
113.69M |
|
$-1.64 |
|
$-1.64 |
|
| Balance Sheet Financials | |
|
Current Assets |
$291.91M |
$64.38M |
|
$148.78M |
|
$440.69M |
|
$38.52M |
|
-- |
|
$83.45M |
|
$121.97M |
|
$318.72M |
|
$318.73M |
|
$318.73M |
|
113.93M |
|
| Cash Flow Statement Financials | |
$-122.87M |
|
$12.22M |
|
$99.89M |
|
$57.05M |
|
$46.28M |
|
$-10.76M |
|
$41.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1542.63% |
|
-1542.63% |
|
-1470.13% |
|
-1366.46% |
|
-1366.46% |
|
$-123.60M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
3.85 |
|
94.76 |
|
-58.44% |
|
-58.44% |
|
-42.27% |
|
-58.44% |
|
$2.80 |
|
$-1.09 |
|
$-1.08 |
|